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The burden of diabetes is no longer restricted only to high income countries.   The global 
incidence of diabetes is rising as many low-income countries are transitioning into altered diets and 
increasing urbanization.  Kenya has a diabetic prevalence ranging from 3.3% to 12%, depending on the 
population measured.  This article explores the current Kenyan health sector regarding diabetes 
management with the objective of delivering methods to improving health outcomes, while saving money 
in healthcare expenditures.  In 2010, only 23-30% of the non-diabetic population had a “good” 
understanding of diabetes.  As one of the first national efforts, the Kenya’s National Diabetes Program 
2010-2015 was launched to strengthen diabetic care within the country through targeted categorical 
interventions. The interventions are working but their efficacy may be limited by low healthcare 
workforce capacities, short-term educational engagements, geographic distribution of care, and healthcare 
expenditures.  Alternatively, Kenya’s mobile technology marketplace is robust and growing with one of 
the most advanced mobile banking systems globally.  Moreover, studies have confirmed telemedicine 
interventions work in chronic care management in Kenya.  Consequently, a mobile assisted management 
system is proposed to aid Kenya’s patients, healthcare workers, insurance providers, and the ministry of 
health (MOH) in diabetic management.  The proposed system’s core components are as follow: 1) cellular 
glucometers for patient blood glucose measurement, tracking, and education, 2) patient application for 
health information, 3) healthcare worker application for patient management and communication, 4) 
insurance and MOH applications for broader drug and patient management.  These components, used 
together, can improve patient outcomes and save money in health related expenditures.  It is 
recommended that the NHIF and MOH conduct a pilot of this system with the diabetic population to 
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Diabetes Across the World  
 
The burden of diabetes is no longer restricted to high-income countries. The global incidence of 
diabetes is increasing as many low-income and middle-income countries are transitioning into different 
diets, increasing urbanization, and living more sedentary lifestyles.
1
 While the prevalence of diabetes still 
may not outweigh the prevalence of other communicable diseases in many low-income nations, it may 
quickly become a financial liability, especially if patients are poorly managed.
2,3
   For technical reference, 
the World Bank classifies countries into different economic categories by their gross national income 
(GNI) per capita.  The full classification as provided by the World Bank is listed in Table 1.   
            In high-income countries 
diabetes is one of the leading 
causes of illness and leads to 
numerous other life changing 
complications.
5
  Currently, high-
income countries expend more 
resources on diabetes, than 
middle- and low-income 
countries, despite the higher 
burden of disease in these countries. The higher burden of disease is due in large part to the greater 
populations in the middle-income countries.  Table 2 more fully explains the substantial differences 
between income, prevalence percentages, and current expenditure as documented by Bloom and 
colleagues.
5(p25)   
 
 
        
  Table 1. Country Economy Classifications4   
  Country Classification Gross National Income per Capita   
  Low-income $ 1,035 or less   
  Lower-middle-income $ 1,036 - $ 4,085   
  Upper-middle-income $ 4,086 - $ 12,615   
  High-income $ 12,616 or above   




 Most projections show the global prevalence of diabetes continuing to grow from 6.4% in 2010 to 
7.7% in 2030.
1(p7),6
  This forecast is primarily accounted for by increased diabetic prevalence in middle- 
and low-income countries.
1(p7) 
  It is expected that these countries will experience greater changes due to 
increasing urbanization, lifestyle, and diet than high-income countries.  Correspondingly, total 
expenditures on diabetic care made by the middle- and low-income countries are estimated to overtake 
the total expenditures of high-income countries by 2030.  Bloom et al. project that high-income countries 
will be spending less and that middle- and low-income countries will be spending more in direct cost for 




Diabetes in Sub-Saharan Africa 
 Focusing on a smaller geographic subset, Sub-Saharan Africa (SSA) has not been immune to the 
changes in the incidence and prevalence of diabetes over the past few decades.  A listing of SSA 
countries, as defined by the United Nations, are listed in Appendix A for reference.
7
   Hall et al. explains 
the reported diabetes increase in SSA has been solely accounted for by type 2 diabetes due to incomplete 
                
  Table 2. Cost of Diabetes: Breakdown by Economic Classification for 20105(p25)    






as % of 
World Total 
Indirect 
Costs as % of 
World Total 
People with 
Diabetes as % of 
World total   
  High $341.5 74.7 90.8 49.8 26.2   
  Upper Middle $28.1 96.1 7.5 36.8 33.8   
  Lower Middle $6.0 97.5 1.6 12.6 34.3   
  Low $0.4 16.2 0.1 0.8 5.7   
  Total $376.0 284.5 100 100 100   
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survey data on both type 1 diabetes and gestational diabetes.   Historically, research and reporting data for 
Type 1 and gestational diabetes has not existed or has been founded on previously diagnosed cases, 
instead of representative population surveys or screenings.
3(p8),8
  In fact, SSA is projected to experience 
the greatest percentage increase in prevalence over the next 20 years, going from 12.1 million in 2010 to 
23.9 million in 2030, a 98 % increase.
1(p7)
  While the overall number of people affected by diabetes will 
likely remain higher in Asia, North America and other regions, the incidence rate in Africa appears to be 
escalating at a faster rate.
1(p8)
 The rise in SSA is generally thought to be due to common risk factors such 
as urbanization, diet changes, obesity and inactivity.
2(p102)
  The rising incidence may reflect an increase in 
risk factors rather than any medical anomaly.  Genetic predisposition or vulnerability has also been 
mentioned by multiple researchers but Cruickshank et al. discovered that caloric imbalances and 
“intergenerational socioeconomic influences” are more influential in the development of diabetes than 
genetics.
9
  Even so, the SSA prevalence increase necessitates an intervention, especially as researchers 
Azevedo and Alla have discussed, this region has struggled with diagnosis, education, and medical 
resources.
2(p103-106)
  If diabetes and its complications were well managed in this region, the increase in 
prevalence might not be as alarming.  However, the complications of diabetes, including cardiovascular 
disease, nephropathy, neuropathy, amputations, acute metabolic complications and more, make the 
disease much more problematic.  Indeed, Azevedo and Alla found that the most common causes of death 
among Africans with diabetes are infection and acute metabolic complications.  Conversely, In high-
income countries, the common causes of death in diabetic patients are renal and cardiovascular 
complications.
2(p103),10  
This significant variation begins to describe the struggles individuals face in SSA 
in managing their diabetic illness.  Additionally, SSA is thought to suffer from the highest rates of 
undiagnosed diabetes in the world,
11
  placing extra burden on the individual and the economies of 
SSA.
8(p2254)
  The International Diabetes Foundation (IDF) estimated that 62% of the total diabetic 
population in SSA was undiagnosed as of 2013 (ages 20-79 years).  Overall, SSA prevalence is at 4.8% 
for those 20-79 years of age (2013).
11(p57)




Diabetes in Kenya  
 Kenya is located on the East African coast at the equator with a population of 43.18 million
12
 
(2012), of which, 24% (2011) live in an urban setting.
13
   Over the past few decades Kenya has seen 
increasing economic growth, yet according to the World Bank, it still remains a low-income country with 
a GNI of $860 per capita as of 2012.
14
  Nevertheless, Kenya has been outperforming the average 
economic growth of low-income countries since 1995.
12
   
 Along with this economic growth, the prevalence of diabetes in Kenya has been increasing with 
estimates and survey data ranging from prevalence at 3.3% (as of 2010)
15
 in rural environments, to 6.6% 
(2008 survey)
16,3(p3)
 and up to 12% (2009 survey).
3(p3),17
  The discrepancies in prevalence rates are 
primarily due to different survey techniques, definitions, and survey locations.  For example, the 2009 
Christensen et al. study, responsible for the 12% prevalence finding, was measured from a completely 
urban environment comprised of type 2 diabetics and patients with impaired glucose tolerance 
(IGT).
17(p306)
  Nevertheless, the Kenyan National Diabetes Strategy states the 3.3% is an underestimation 
of prevalence because of the undiagnosed population.
15(p3)
  In 2013, the IDF reports the Kenyan national 
prevalence at 3.58% and at 4.56% when adjusting for Kenya’s population age profile.
11(p120)
  
While Kenya does not experience the highest diabetic prevalence rates in the world, it historically 
was not focusing significant resources on diabetes management or prevention until around 2010.  This is 
evident by reading the Kenyan report: Kenya National Diabetes Strategy 2010-2015.
15(pv)
  To date, 
diabetes is the only non-communicable disease that Kenya has a national initiative to fight.  All the same, 
Kenya is now dealing with a historical unobstructed rise in incidence of diabetes and its related 
complications.  As the prevalence and incidence of diabetes grow, the Kenyan government has realized 
the importance of managing diabetes to curb the its major complications such as:  nephropathy leading to 
chronic kidney disease (CKD), hypertension, cardiovascular disease (CVD), blindness, neuropathy, and 
more.
15(p6)
  According to Mwendwa et al., in a 2005 cross-sectional study of persons with type 2 diabetes 
in Kenya, with an average duration of diabetes at 10.3 months, individuals had: a 7% incidence of 
retinopathy; 50% with hypertension; 25% with micro-albuminuria; 1% with macro-albuminuria; 40% 
5 
 
with a high LDL cholesterol measurement; and 66% of these were obese.
3(p7),18
   Additionally, only 29% 
had glucose control in ideal ranges.
18
  Other studies, not necessarily from Kenya, show an increase in 
acquiring other co-morbidities not typically thought of with diabetes.  Across numerous geographic 
regions and income classifications, meta-analysis by Jeon and Murray found diabetes was associated with 
a threefold increase in risk for developing tuberculosis.
19





 and a 2.5 chance of developing sepsis.
21(p9),23
 These 
severe complications, partially attributable to diabetes, often require hospitalization increasing the 
financial burden of the disease. 
Kenya’s Health Infrastructure 
Kenya’s overall health infrastructure consists of the following types of organizations: ministry of 
health (MOH) and public health services, private enterprises, non-profits, and non-governmental 
organizations (NGOs).  Health services are classified into tiers ranking from 1 to 6 with level 6 
representing a referral hospital, with the highest ability to provide care. Figure 1 defines each level, 
showing a progression of service ability, however the number of these organizations decrease as one 
moves from 1 to 6.
24
  Based on Kenya National 
Bureau of Statistics data from 2011, there were 
7,549 physicians or 0.181 per 1,000 population.  
Similarly, in 2011, there were 0.792 – 1.26 
nurses and midwifes per 1,000 population, 
depending on the type of nursing qualifications 
used in the calculation.
25
  Despite Kenya’s 
economic growth, the physician ratios are 
relatively low in comparison to other regional 
African nations.
26,27  
Additionally, nurses have 
been unemployed or underemployed due to hiring and/or wage ceilings, even up to 50% during some 
6 
 
years bringing the nurse to population ratio much lower.  Furthermore, due to these issues the healthcare 
workforce has experienced heavy migrations out of the country to work elsewhere.
27(p73)
 
 As another measurement of healthcare availability, based on current MOH data as of 2014, there 
are 115 hospitals in Kenya with 100 beds or more and only 46 with 200 beds or more.  In 2010, the World 
Bank reported the  inpatient hospital availability equated to approximately 1.4 beds per 1000 population.
28
  
Beyond hospitals, there are numerous health centers, medical clinics, and dispensaries distributed 
throughout the country, which focus on care in the outpatient setting.  According to work done in 2008 by 
Noor et al. there has been significant improvement since 2003 in the number and distribution of 
healthcare facilities throughout the country, with 89% of the Kenyan population within 5 kilometers of 





 listed the dispensary count in 2004 at 1,540 and the Ministry of Health database
31
 listed 
the 2014 count at 3,846 in operation. It is difficult to know if both listings are accurate, but the numbers 
are presenting significant (approximated to be two-fold) growth in infrastructure over the past 10 years.  






Beyond the density and distribution of health workers and facilities, equitable access to care is an 
ongoing process. Munge and Briggs claim the distribution of private-for-profit enterprises are 
concentrated in the higher tiers (hospitals) while public or governmental institutions are more frequent in 
the lower tiers.
32
  This pattern has historically had negative effects on equal access to healthcare.  
Research performed in 2003 and 2007 by Chuma et al. has indicated that private-for-profit healthcare 
service delivery favors wealthy individuals over the poor population.  This was especially true for 
inpatient services.
33
  Diabetic patients are not immune to these issues, more often than not, requiring 

















Kenya’s Need Moving Forward 
 Kenya’s growth in diabetic patient population is unlikely to be met by an equivalent growth in 
their healthcare workforce, facilities and financial support.  Additionally, the current patient load is not 
being fully cared for, primarily because of a lack of resources.  Therefore, it is the aim of this paper to 
outline a promising strategy for the use of mobile technologies to assist in diabetic patient management.        
Mobile technologies have been proven to be effective at assisting both the healthcare provider and patient 
with management of care.
34–37
 Care providers can have a better insight into their patients’ actions, are able 
to manage a higher number of patients, and are alerted when patient circumstances need immediate 
attention.  Most importantly, mobile technologies could aid patients in education and self-management, 
which increases buy-in, leading to better outcomes.  Portions of Kenya’s infrastructure, evidenced by 
their mobile banking infrastructure, make it an exceptional candidate towards implementing a leading 
mobile health strategy. 
Methods  
A search for relevant published papers in the past ten years was conducted (2003-2013).   The primary 
search scope started broadly by searching for global trends about the prevalence of diabetes, narrowing 
into the SSA region, and then narrowing to Kenya. Therefore, this strategy combined the words “global or 
world,” “Sub-Saharan Africa,” and “Kenya,” with the following search terms:  “diabetes prevalence,” 
“diabetic complications,” “diabetes management,” “diabetes self-management incentives,” “chronic-care 
management”, “low-income chronic-care,” “mobile technology,” “mobile glucometer,” and “glucometer 
technology.”  All searches were performed through the University of North Carolina at Chapel Hill’s 
institutional connection to Google Scholar; therefore, excluded sources were those inaccessible to Google 
Scholar or those requiring a paid subscription outside those presently available to the University.  Often 
content and references from these articles prompted directed searches for the primary research source.  
Google Scholar was again used for this purpose.  Lastly, the following grey literature sources were used 
for their valuable content: The Communications Commission of Kenya, eHealth-Kenya Facilities, GSMA 
9 
 
Intelligence, IDF, Kenya Health Information System, The World Bank, The United Nations, and The 
World Health Organization.   
Results 
Current Kenyan Programs to Manage Diabetes 
In 2009, The World Diabetes Foundation (WDF), in coordination with the Ministry of Public 
Health and Sanitation (MPHS), developed a project for Kenya entitled, “The National Diabetes 
Programme.” This project called for “strengthening the healthcare system to address diabetes by building 
capacity for the health facilities and increasing community participation in health care delivery.”
38
  The 
primary action was to develop a strategic guideline and action plan, which the Kenyan MOH initiated the 
following year with the help of a few organizations and funding by the WDF.  The guide, known as the 
Kenya National Diabetes Strategy 2010 – 2015 (KNDS), is a multi-faceted strategy to “consolidate and 
improve the quality and coverage of diabetes care services in Kenya.”
15(pv)
  The document has the 




3. Resource Mobilization and Prioritization 
4. Capacity Building 
5. Partnership and Coordination 
6. Diabetes Policies, Legislation and Regulations 
7. Research 
8. Monitoring and Evaluation 
Each of these strategies have corresponding action items, monitoring indicators, time periods, lead agency 
responsibilities, and partnership recommendations.
15(p15-24)
  The WDF-initiated program has set high 
standards and Kenya has met a few of them as of 2013, even as the project continues.  Importantly, Kenya 
has delivered on the expectation of a national strategy, outlining further action plans.  As reported on the 
WDF website, awareness meetings and screenings have largely been successful, with meetings reaching 
an estimated 8 million people.  Screenings have revealed over a thousand new diabetic patients, out of the 
27,964 people screened.  This represents almost 18,000 more participants screened beyond the 
10 
 
expectation.  A total of 83 care clinics have been established since the 2009 WDF program launch date. 
38
  
Before this particular program, the WDF completed two previous programs in Kenya targeted at diabetes, 
specifically for enhancing diabetic foot care and diabetic awareness through preventative care and 
enhancing care.
39,40
  Both were mostly successful according to the WDF results.  The National Diabetes 
Programme initiated in 2009 is ongoing, but the results for the Diabetes Management & Information 
project ending in 2010 are listed in Table 3 below.   
 
Kenya’s Education Level on Diabetes   
In 2010, Maina et al. were able to show that only 23-30% of the non-diabetic population had a good 
understanding of diabetes’ signs and symptoms, its causes, and complications.  Conversely, 70-77% had 
little to no knowledge on these three scales.
41
    Slight variances depended on education level attained and 
country district.
41
  Recent data was not found for diabetes related education of the diabetic population. 
While the general public’s education appears to be lacking, education for healthcare workers is 
improving, through the WDF program mentioned above.   Training has not fully met the WDF goals, but 
    
 Table 3. WDF Diabetes Management & Information Project Expectations versus Results
39,40
  
 Expectations  2010 Results   
 42 diabetes clinics established 32 diabetes clinics established in district hospitals  
 200 mini-clinics established 91 diabetes mini-clinics at dispensaries and health 
centers 
 
 500 doctors trained 736 doctors trained  
 1,000 para-medicals trained 839 paramedics trained  
 3040 nurses trained 2,234 nurses trained  
 250 dieticians trained 393 dieticians trained  
 2,500 lay educators trained 4,169 lay educators trained  
 250,000 people diabetics receive education 
annually 
no data available  
 5 million people educated on risk factors & 
healthy lifestyles 
4.4 million reached by 4-6 hour awareness activities  
 no data available 663,203 people reached by one-day education 
sessions 
 
 no data available 121,763  screened with 13,029 with diabetes of  
which 1890 were not aware of their condition 
 
    
11 
 
time still remains and significant headway has been made.  Results to date for the WDF’s National 
Diabetes Programme are as follows: “95 doctors, 439 nurses, and 553 paramedics have been trained.”
38
     
Kenya’s Economics of Health 
 In 2001, African Union countries, including Kenya, pledged to spend at least 15% of their annual 
budget on improving the health sector.
42
  As of 2009/10, health sector expenditures were at 4.6% of the 
total governmental expenditure, a drop from 2001/02 at 8.6% and well below the targeted 15%.
43    
According to an interview with S. Masinde (Mar 2014), the MOH covers a significant share of cost at the 
lower levels of care within public facilities.  The major items discussed regarding MOH coverage were as 
follow: 
 Most primary care is free at health centers and dispensaries (both level 2 facilities) but drugs are 
usually not free. 
 Secondary level of care (level 3 and 4 Facilities) often requires a fee of 10 or 20 Kenyan Shillings 
(Ksh) but after that fee is paid, care is free and the MOH pays for it.  The patient is responsible 
for overnight ward charges that cost around 100 Ksh per night/day. 
 Maternity care is usually always free.   
 Basic surgeries at level 3 and 4 cost around 10,000 Ksh to the patient and the MOH covers the 
rest of the cost. 
 At level 5 and 6 facilities, the typical cost to the patient for surgery rises significantly. Also, at 
levels 5 and 6, public ward cost are typically 200 Ksh per day/night and at level 6 hospitals, 
private room cost can be up to 1,500 Ksh per day/night for the patient. 
 
In 2005-06, approximately 10% of the population was covered under some form of insurance and 
the National Hospital Insurance Fund (NHIF) accounted for 40% of that insurance market share. The 
remaining 60% was covered by private insurers.
32(p3)
  By 2012, the NHIF projected its insurance base at 
20% of the country’s total population, but the benefits provided were almost solely for inpatient 
services.
44
   Of the 20% covered, civil servants and disciplined service members are given extra benefits 
beyond the standard coverage, in accordance with a government contract.
45
   Membership to the NHIF is 
mandated for those working in the formal sector and for their dependents.  Formal sector employment is 
typically made of professions and jobs that are taxable by the government.  As of 2014, formal sector 
premiums range from 30 Ksh for a person making 1,000-1,499 shillings per month, up to a premium of 
12 
 
320 Ksh per month for those making 15,000 Ksh per month or more.  The level of benefits paid out by the 
NHIF depends on the type of institution where the patient receives care.  Category A facilities are always 
public institutions that are NHIF accredited and benefits are typically 100% paid by NHIF for inpatient 
services.  Category B institutions are typically private, mission based institutions and NHIF pays for most  
services in these facilities outright, but will charge a copay for required surgeries.  Finally, category C 
institutions are private facilities and the NHIF will pay an unspecified amount for services at these 
locations.
45
  Table 4 gives a summary of the NHIF accredited facilities based on self-reported NHIF data. 
Healthcare received in foreign countries may actually be reimbursed if the patient qualifies.  Most patients 
under NHIF would only qualify for a 1,700 Ksh payment per day for foreign care.  However, civil 
servants and those in the disciplines services 
are able to receive extra benefits.  While 
completely dependent on job category, some 
civil servants and disciplined services 
workers have no cap on their benefits.  Most 
of the widely published benefits are related to 
extra outpatient services and diagnostics.
45
   
Other payers, including individuals, account for a significant portion of the total health 
expenditures (THE).  The majority of citizens that are unemployed or who work in the informal sector are 
not covered under any health insurance plan and pay by out of pocket (OOP) expenses, by MOH 
subsidies, or through NGO benefits.
32(p2)
    In Kenya, OOP expenses are customarily paid up-front, before 
healthcare service is rendered, which can be significantly burdensome for those in need of care in a short 
period of time.
32(p7)
   Payments for all healthcare expenditure can be broken into the following categories 
as defined in Figure 3.  
     







Total Beds in 
Category Group 
 
 Category A 152 20,137  
 Category B 172 11,441  
 Category C 128 5,516  
 Grand Total 452 37,094  




Overall the cost of diabetes is the summation of medical visits, medications, diabetes supplies, 
travel costs, loss of productivity, and possibly hospitalization.
46(p15)   
The annual cost to care for diabetes 
and diabetic complications in Kenya as a whole is estimated at $ 22,073,370 (USD) in 2010, which 
equaled approximately 5% of Kenya’s total health expenditures (THE).
6
  Kenya’s expenditure by type of 
service is known for the THE (Figure 3), but it is not broken into care categories for disease-specific 
considerations such as diabetic care.   Total direct cost for medications and care were not available at the 
time of this writing.  However, it is known that the NHIF does cover medication and supplies for most 
inpatient visits, and if the beneficiary is a civil servant or disciplined services member, they qualify for 
further coverage of medication and supplies on an outpatient basis.   For those not covered under the 
NHIF, most medications and supplies must be covered by OOP.  Of the commonly known complications, 
 
 








































from diabetes, there is some economic data available for caring individuals with nephropathy.  
Hemodialysis, which is required in patients with severe diabetic nephropathy, reportedly costs between 
$50 (USD) per session
47
 up to $173.00 (USD) per session,
48
 of which NHIF may pay up to 2,300 Ksh
49
 
($26.47 USD on March 26
th
, 2014) that represents less than 25% of the estimated average cost.  As of 
2012, there were only about 100 dialysis machines working in the country, leaving many in need without 
access to this treatment.
50
  Another example relates to diabetics suffering from renal failure.  Kidney 
transplants are the last remaining option for those in renal failure and with an identifiable suitable donor.  
These procedures cost on average $17,500 (USD) in India
51
 and around 500,000 Ksh ($5,755.00 USD on 
March 26
th
, 2014) at Kenyatta Hospital in country.
52
  Many patients may go to India for this procedure for 
the high standard of care, reported good outcomes, shorter waiting times, and increasing popularity (S 
Masinde, oral communication, Mar. 2014).  Another serious complication which carries significant 
burden for the payer and patient both is lower-limb amputation.  Ogeng’o et al. found significant results 
when studying amputation caused by diabetes versus non-diabetic amputation.  Unfortunately, in Kenya, 
like other geographical regions, diabetics often suffer greater levels of infection post-amputation than do 
non-diabetics.  The average post-amputation hospital stay in Kenya was observed to be 11 days for non-
diabetic patients and up to 19 days for diabetic patients, resulting in significant added cost.
53
 
Another readily available cost approximation at the individual patient level, is the cost of insulin; 
under the new Novo-Nordisk distribution plan, it is about $0.20 per day or $73 (USD) per year.
54
 In early-
2012, Novo Nordisk partnered with Kenya to provide subsidized access to insulin throughout the 
country.
55,56
    As of early 2013, this partnership has brought insulin access to about 2,600 patients and 
lowered the unit cost of an insulin vial from approximately $21.60 to $6 USD.
56
   Previous studies 
revealed a history of poor distribution of subsidized insulin and medication, even a markup of subsidized 
pricing to generate profit.
57
  Medication access at the rural local levels is notably the worst.
57(p128)
  To 
battle price markups, in 2010, Novo Nordisk pre-stamped the cost of the insulin vials with the price and 
signed memorandums of understanding with every portion of the distribution chain.
58
    Before the recent 
2012 partnership, Novo Nordisk remarked that the Kenyan government bought insulin “based on budget, 
15 
 
not on need” which often led to shortages.
57(p128)
  Current data out of Denmark regarding the renewed 
partnership shows gains in increased insulin availability and compliance by distributors,
58
   but long-term 
evidence has yet to be gathered.   
 
Kenya’s Technological Infrastructure 
Kenya’s growth in mobile infrastructure over the past 10-15 years has exceeded expectations.    
Safaricom, the largest network provider in country with 65% market share (2012),
59
 is one of Kenya’s 
largest companies by market value.
60
  Three other companies compete heavily with Safaricom: Orange, 
Airtel, and Yu.
61,62
  As of 2014, cellular subscriptions have risen to about 32.3 million, which equates to 
approximately 72% of all Kenyans owning a personal phone;
62 
and a 2010 survey has shown that 90% 
have access to a phone even when they may not personally own the device.
63 
  Ownership of a personal 
computer is much lower, but growing.  Wireless technologies in use range from 2G, 3G, limited 4G, and 
WiMAX technologies.  4G technology exist in Nairobi and Mombasa, but is currently heavily restricted 





The Kenyan cellular network covers about 96% of the population based on where Kenyans 
actually live.
62
   About 98% of these connections are on a Pre-Paid basis,
62
 the standard in low-income 
countries.  Another large use of cellular devices in Kenya comes by way of mobile banking or mobile 
money transfers (MMT).  There are currently 25.1 million subscriptions to this service.
65
  Safaricom 
maintains the highest market share, as they were the company to start the service through their M-PESA 
program.
59
 In 2010, data showed that 4.26 billion USD had flowed through MMT, which was 13.3% of 
the country’s GDP.
66
  Lastly, feature phones currently dominate the market with 83.9% of the market, but 
smartphone adoption has been increasing.  While estimates vary on adoption rate and market penetration, 







Current Technology Available for Diabetic Chronic Care 
In 2002, LG was one of the first mobile phone companies to release a glucophone, a phone with 
the ability to read glucose tests.
68
  The purpose was to give users an easy alternative to the basic 
glucometer and be able to send the important data to their clinician.  As the first of its kind, the data 
sending abilities operated through Short Message Service (SMS).  Ten years later, Telcare, a US based 
company, is now producing a dynamic glucometer with cellular sending and receiving abilities, which 
meets both FDA and HIPAA requirements in the Unites States.  The Telcare BGM lacks traditional voice 
capabilities, but has enhanced the user interface, patient, and clinician experience.
69
  Bluetooth enabled 
glucometers and direct connect glucometers are also widely used as an added appendage to a smartphone 
with a smartphone application.  A sample listing of previous and current mobile glucometers, sorted by 
abilities, is available in Appendix C.  These devices use various techniques to send measurement data to 
the central database and the most efficient devices  (though with a higher purchase price) use built-in 
cellular systems, incurring no extra cost to the patient.
70
  As patient side technologies have matured 
greatly, so have clinical side tools.  Electronic health records (EHR) have increased in adoption at an 
incredible pace, through voluntary and forced adoption.  Some of these are represented with disjointed 
systems and some as coordinated, country-wide systems.  In Kenya, there is one main system for 
aggregated data
37
 and various EHR systems in the marketplace.  However, Kenya is striving to 
standardize the EHR deployments and was seeking to deploy electronic medical records (EMR) at 600 
sites in 2013.
71
  Musya et al indicated in 2012 that in HIV care this EMR implementation is a progression 
toward one, “all encompassing” EHR.
71
   
Several reports have demonstrated the efficacy of joining mobile technology with chronic care. 
Of note, meta-analysis by Cole-Lewis and Kershaw recognized text message reminders alone were 
observed to have an impact on tighter diabetic management and the lowering of glycated hemoglobin 
(HbA1c) levels.
35
  Additionally, the same meta-analysis displayed significant positive effect when 
observing management of weight loss and smoking cessation.
35
 In a three month study by Kollmann and 
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Riedl, there was significant improvement of HbA1c levels after three months of entering glucose 
measurements into a phone and accessing records through a patient portal.
34
  In another meta-analysis by 
Liang et al., they explored the use of mobile phones specifically for diabetic control and found 
“statistically significant improvement in glycemic control and self-management.”
36
 In studies where 
feedback is given based on data entry, results have shown positive, statistically significant correlation 
with reducing HbA1c levels and in patient satisfaction.
34
  Furthermore, combining mobile management 
with physical visits to healthcare providers appeared to have a stronger impact.
36
  While not specifically 
related to diabetic chronic care, research in Kenya by Lester et al. has shown that cell phone 
communication via SMS can significantly improve HIV antiretroviral treatment adherence when 
compared to controls without communication.
72
   
 
Discussion 
Kenya’s current project to manage diabetes, headed by the WDF, has made progress, most 
notably with education of health workers. Numerous screenings have contributed to the recognition of a 
greater incidence of diabetes, but recent data indicates a large population may yet be undiagnosed.  
Currently proposed methods to increase awareness in the Kenya National Diabetes Strategy 2010-2015 
appear reasonably effective but results indicate that only short-term awareness campaigns are being 
used.
38
  Evidence of using only short-term campaigning may be due to lack of published results, but it 
may be an indication of a deeper focus on short-term strategies.  Research suggests diabetes awareness 
remains low, despite education efforts. Since the WDF project started in 2009, the capacity building 
process has been almost completely focused on building human resources through training.  As 
mentioned earlier, numerous healthcare workers have been trained on diabetes; however, the new number 
trained is not likely to meet the demand of diabetic patients especially as the prevalence and incidence 
grows.
73(p21,23)
  To effectively manage the growing diabetes case load, the following items are needed 1) 
more health workers, 2) available workers need to be able to effectively manage more patients and/or 3) 
patients need to improve self-management.   
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Kenyan capacity building also refers to building a better distribution network of medications and 
supplies.  Current efforts are working but appear to be moving slowly, as is indicated by the Novo-
Nordisk project that only affected 2,600 patients with insulin injections in the first year of deployment.  
Known issues with subsidized medicines may be hampering this project as it has with previous projects.  
Nevertheless, medication disbursement projects could benefit from a heightened measure of oversight, 
both in the distribution channels and in patient procurement.  Insulin is the drug of choice in advanced 
diabetes management, but oral medications used earlier in the disease state, such as metformin and 
glibenclamide, need better distribution and subsidization as well.
57
   
Mobile Assisted Management Proposal 
 
For being classified as a low-income country, Kenya has many advancements that rival high-
income countries regarding telecommunications.  Nearly every indicator from Kenya shows that the 
mobile market is growing with more adoptions of service usage, diversity of technology, greater access to 
the internet, and more.
74
  This is advantageous in Kenya where the population is largely rural and access 
to specialized care is often focused in urban environments. As mobile technology continues to develop 
and Kenya’s usage increases, access to specialized care through telemedicine can become more 
distributed.  Because of current and expanding mobile use and historic welcomed adoption of new mobile 
technologies, it is recommended that Kenya utilize existing mobile technologies to aid in chronic diabetic 
management and resource allocation. Mobile assisted management (MAM) has the capability of assisting 
in the management of glucose levels, educating patients, assisting healthcare workers in daily and 
emergent activities, and in influencing healthcare payer and MOH decisions through real-time 
information.   
Before going further, the phrase “mobile technologies” encompasses a vast array of technologies, 
but for the sake of this argument, it encompasses the following components, at a minimum:  
1. Cellular network connected to main Internet grid 
2. Glucometer (cellular enabled) 
3. User interface (UI) for displaying glucose readings and relevant information on glucometer 
4. UI for input of ongoing, relevant patient information, such as medication or complications 
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5. Relational database to store patient readings and extra data 
6. Application for displaying historical patient data to patient’s glucometer or over the Internet 
7. Application for healthcare workforce management of patients 
8. Application for management of staff, medication distribution, and project 
 
Other equipment or technology may be necessary to function as an adjunct to the systems above, but this 
list covers the majority of items needed.  Importantly, the technology and intelligence for these items 
already exist.  Indispensable and desirable functions of the system are listed in Appendix D.  
In an established environment, the hypothesized MAM system begins with the patient taking 
every blood glucose measurement on their cellular glucometer.  The current measurement is 
simultaneously presented to the patient and sent to a secure database, using a secure SMS or other cellular 
connection. Using older SMS technology allows for a greater coverage area, with use on nearly any 
mobile network, globally.   Based on the patient’s current and previous information, the device uses 
internal algorithms to present relevant data and educational material to the UI.  Cues to take medication, 
eat, or contact a medical provider can be given as needed.   In a recent study detailing the effects of a 
system nearly identical to the MAM system, Javitt et al. highlighted the importance of this automated 
“coaching and guidance” in its ability to prioritize healthcare worker interaction and provide automatic 
feedback to the patient.
75 
 Once the information arrives in the database, it can then be stored and later 
accessed by the patient or appropriate medical staff.  Medical workers are able to view numerous patient 
records at once, using intuitive displays ranking patients by type of care needed.   From the same 
application, medical workers can send messages to the patient or contact other workers for assistance.  
Each level of healthcare provider, from the community health worker (CHW) up to the national referral 
hospital physician, can have varying levels of access to the patient’s history.  On the spot access can be 
granted to medical staff by using their information in combination with the patient’s information or the 
glucometer’s device information. 
 In addition to the traditional healthcare worker, local dispensaries and other medication access 
points should have a basic level of permissions to the system in order to access the medication portion of 
the patient’s record.  Allowing dispensaries access to the patient’s medication history allows them to see 
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historical usage and input current medication allotments, which has multiple positive effects. Firstly, it 
may help to reduce counterfeit pharmaceuticals in the market.  Secondly, it may help to reduce 
medication errors at the patient level.  Thirdly, this function gives the MOH heightened oversight of 
medication supply chains.  This data influences medication and supply purchases as well as can inform 
the regional diabetic management agenda.  Aggregated patient, healthcare worker, and medication data 
are essential for the MOH to effectively manage the diabetic patient load.  
With the stated strategy, the cellular glucometer has the capability to raise the level of self-
management on its own.  However, the MAM system also allows the MOH and other payers in the 
system to reward or incentivize achievements in self-management.  Patients and physicians generally 
agree that it can be an effective addition in motivating effort for short-term education goals, as well as 
long-term care plans.
76
   Financial incentives, medication incentives, or other forms of reward can easily 
be allotted to those patients who do well with medications and their glucose measurements.  Certainly, an 
incentive program must be carefully crafted to ensure the poorer populations or inherently sick 
populations are not disadvantaged.   Nevertheless, the MAM system allows for tracking patient 
management, thus creating a framework where incentives and rewards can be effective and even 
cyclically build better self-management.  Many advantages have been listed and the main items have been 
summarized in the following section.  
Chief Advantages Summary of Mobile Assisted Management System Proposal 
Patients: 
1. Support patient education through dynamic, real-time feedback based on patient symptoms 
2. Assist patient in understanding of short- and long-term effects of proper management 
3. Support patient education through regular messages - automated or sent by medical worker 
4. Aid patient adherence to prescribed medication protocol through automated reminders 
5. Automatically send emergency indicator on extremely high or low blood glucose readings 
6. Access to historical glucose records and diabetic medical checkup information 
7. Personal access to limited medical opinion  
8. Healthcare action plan accessible via device 
9. Patients benefit from increased oversight of medication and supply control by the MOH 
because they can more reliably receive medications and supplies at set costs 
10. Patients can be rewarded for good self-management, through various strategies 
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11. Friends or family members are able to remotely check patient’s status, which may be 
essential in the care of minors and some elderly 
 
Healthcare Workers: 
1. Able to see diabetic patients under personal care, in one system, at one time 
2. Automation of patient care for minor tasks 
3. Receive alerts for patients out of blood glucose range or in emergent situation 
4. Management is easily shared among workers 
5. Less personal visits are necessary with daily monitoring of a majority of patient base 
6. Able to see historical trends and medical information for patient 
7. Provide a simple way to connect with patients 
 
Healthcare Payer (e.g. MOH, NHIF, or insurance company): 
1. Aggregate data influences decision making for risk factor management and intervention 
analysis 
2. Assist with planning campaigns and strategy 
3. Directly measure diabetic population in real-time 
4. Allow for regulation of medicine distribution for greater cost savings and transparency 
5. Save money through better management, lowering complication rates 
6. Adapt technology to aid in other diseases,  non-communicable and communicable 
7. Assist in understanding of geographic distribution of care 
 
Necessary Infrastructure for Implementation in Kenya 
 
 Besides policy obstacles and development of stakeholder buy-in, to initiate the project suggested 
several factors must be addressed.  Firstly, the proposed MAM system is based on technology in which 
the core infrastructure currently exists in the global marketplace.  However, some minor re-designs or 
alterations may be necessary for adaption into the Kenyan setting.  The Kenyan telecommunications 
market already has a robust 2G network in place with growing coverage of 3G and 4G networks.  The 2G 
backbone is likely sufficient for basic patient use and the 3G and 4G networks will continue to add more 
services as they expand.  These services will grow and be maintained regardless of the health sector’s use.   
Further infrastructure is categorized into items oriented towards patients, healthcare workers, and payers.  
 For the patient, the main items necessary are a cellular glucometer, compatible testing strips, and 
proper medication.  The higher end cellular glucometer with a graphical user interface can be purchased 
at the manufacturer’s suggested retail price for approximately $150.00 (USD), with lower end devices 
costing less.  Additionally, some devices include data transmission at no extra cost to the patient.  Please 
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see Appendix C for a listing of published prices for numerous models.  Due to the price of the device, part 
or full purchasing responsibility may fall on the MOH or insurance provider, as the individual may 
default to a cheaper model when given the choice.  Beyond the glucometers, the key component to 
implement is a database and related web based application or portal.  Database applications described 
above exist in other countries and they are often tied to EHR systems.   Existing database applications, 
specifically designed for diabetic management, can be purchased and adapted for Kenya’s usage or 
developed from the ground up.  According to the Jeanine Ayers, a US based software engineer and 
architect, it would take an experienced engineering team approximately 2400 hours to build a working 
prototype of the database and applications from the scratch (phone and email correspondence in April 
2014).  However, this does not include time to build the cellular glucometer, quality assurance of the 
software, or project management.  Mrs. Ayers’ estimated analysis for time required for the core 
components can be found in Appendix E.  As an alternative, existing databases and applications can be 
purchased and linked to existing Kenyan EMR/EHR using an application interface.  This affords the 
ability to use a prebuilt, customized diabetic management application with the usability of existing EMR 
solutions.  A good example of a blending of these options is the Telcare system which uses its own 
cellular glucometer and applications and databases, with the ability to link to other systems.
77
   If a limited 
pilot project is pursued for proof of concept, existing applications and associated database can likely be 
procured on a trial basis.  Notably, medication supply chain management functions may need to be left 
out of a pilot to simplify early implementation.  Additional cost for the system is further explored below. 
Economic Value of Using a Mobile Assisted Management System 
 
The burden of cost for this system is likely to be split across the government, insurance providers, 
and the patient.  The medical and financial benefit of the devices, correlating applications, and 
management must outweigh the cost to train, purchase, deploy, and utilize.  In economic analysis, both 
short-term and long-term cost savings are important to consider.   It has been thoroughly proven  in high 
income countries that management of blood glucose can lead to lower diabetic complications and lead to 
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long-term cost savings; however, savings in the short-term can be realized as well.
75(p199),78-79
  For 
example, in the United States, a case study done with the Telcare BGM device decreased medical claims 
costs by an average of $3,384 (USD) per person in one year.
75(p121)
  This significant savings does not even 
account for increased work productivity or a decrease in absenteeism, which the study by Javitt et al. 
further estimated at over $3,000 (USD) per worker with diabetes per year.
75(p122)
  These findings are 
significant because they reveal the financial implications for managing chronic conditions efficiently, 
even when measuring results under short-term constraints.      
For the NHIF and other major payers, this system could lead to savings as it has in the US.  Under 
the current NHIF model, which only pays for inpatient services for the majority of its beneficiaries, the 
value of the proposed MAM system can be measured by the monies saved for reducing inpatient visits 
and emergency visits, which often end in serious morbidity and even mortality.    Treating poorly 
managed diabetic cases often carries significant financial cost for the payer, and patient OOP expenses 
cannot be understated.  As the NHIF progresses into paying for outpatient services for a greater 
percentage of beneficiaries,
45
 the benefit of this system would become even more apparent.   For the 
MOH, which accounts for a considerable portion of the THE, similar savings can be assumed at the 
primary and secondary care levels.  Because the MOH does not cover as much of the financial burden of 
the patient at higher levels of inpatient care, in comparison to the NHIF, the MOH’s short-term savings 
may be less substantial.  As with most drastic changes in healthcare, a pilot project would help identify 
and quantify the various costs of the system, allowing comparisons against the financial and medicinal 
status quo.   In order to determine a reasonable return on investment for both the formal and informal 
working population, the costs this system adds to health expenditures that are not covered by savings in 
other expenditures, should be evaluated against the value added to the wellbeing of the patients and the 
satisfaction of the healthcare staff.   Costs and saving for implementing the system are a major factor, but 







Firstly, the MAM system is not meant to fully replace current efforts targeting the establishment 
of new clinics and services or education initiatives that Kenya is working to increase.  The system is 
meant to augment these required resources and provide another access point to healthcare service for the 
patient.  This system cannot replace hands on or directed service by a healthcare professional, but it may 
be able to assist the healthcare professional(s) in delivering that care.  Furthermore, the MAM system, in 
its current design, is not a prime candidate to deliver preventative services; its primary purpose is to aid 
patients currently diagnosed with diabetes or IGT and the healthcare workers serving these patients.  
While the system represents an opportunity to improve health outcomes and financial stewardship 
in diabetic patient management, deploying the system does require upfront financial and political 
investment to implement. Yet, the financial burden primarily lies in the cost of providing normal access to 
standard diabetic healthcare for the population: glucometers, testing strips, and required supplies and 
medications.  These expenses represent the greatest portion of cost in this system, which exist regardless 
of any management scheme in place.  Therefore, making provision for those supplies must become part of 
any successful diabetic chronic care management regimen.  The political investment to deploy this system 
nationwide should start with factors already in place and in favor of the system.  Diabetes and its effects 
on the Kenyan population is already on the national healthcare agenda, which is evidenced by the KNDS.  
Similarly, electronic management of health records is a nationally recognized goal
80
 and efforts in HIV 
care have led the way.  As a second step in policy formation, further data collection, analysis and 
dissemination of known information must take place.  A localized pilot program could significantly aid 
this effort by presenting a proof of concept, serving to justify the change.  A pilot can supplement missing 
data on current diabetic care and demonstrate the proposed MAM system’s positive effects.  A third step 
is to adjust the proposed system according to any new findings to help it fit Kenya’s health sector more 
appropriately.   Finally, implementation of the MAM system would require numerous interactions 
between stakeholders, such as the MOH, NHIF, NGOs, private insurance companies, healthcare staff, 
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private and public healthcare facilities, patients, mobile phone companies, and pharmaceutical companies.  
This system and its resulting policies require broad changes and it is paramount for stakeholders to have 
buy-in with defined responsibilities. To be effective, each organization must understand the positive, 
neutral, and/or negative consequences of implementation.  A successful coalition of stakeholders will 
include at the least, the main payers in the healthcare market: the MOH, NHIF, and private insurers.  




Overall, the tools and abilities to implement a mobile assisted management system in Kenya 
currently exist, and cost savings could be realized through adaptation and adoption, in support of the 
growing diabetic population.  However, before the MAM could be truly effective for the whole diabetic 
Kenyan population, work remains to develop regular diabetic screenings, advance education about 
diabetes to the public, as well as ensure diabetic patients have access to needed supplies and medications.  
A recognized starting point for this system, and a potential pilot project, could involve NHIF’s 
beneficiaries and especially, civil servant and disciplined services beneficiaries, as their benefit package 
includes care beyond the normal employee in the formal sector.   An organized pilot project, with this 
group or another cohort, is recommended to evaluate the standardization of systems processes, expand the 
reach of trained healthcare professionals, provide greater access to the diabetic population in the 
management of their condition, reveal missing data, as well as determine intended and unintended 
















4. Burkina Faso 
5. Burundi 
6. Cameroon 
7. Cape Verde 
8. Central African Republic 
9. Chad 
10. Comoros 
11. Congo (Brazzaville) 
12. Congo (Democratic Republic) 
13. Côte d'Ivoire 
14. Djibouti 






















37. Sao Tome and Principe 
38. Senegal 
39. Seychelles 
40. Sierra Leone 
41. Somalia 
42. South Africa 


















Appendix B: Kenya’s Total Health Expenditure by Category 
 
            
  Table 5. Total Health Expenditures by Financing Payer (Kenyan Shillings)
43(p16)
   
 Payer Years   
  
 
2001/02 2005/06 2009/10   
  Ministries of Health  27,706,318,188 36,078,350,970 33,459,601,497   
  NACC -- 1,752,413,862 1,301,728,082   
  Other ministries 42,566,019 -- 296,253,589   
   Local Authorities  848,325,319 588,514,805 1,116,889,928   
  NHIF 3,233,803,375 3,791,427,337 5,803,838,476   
  Parastatals 2,317,408,402 1,348,725,333 2,957,902,148   
  Private Employer Insurance  3,098,297,945 5,543,993,319 8,252,228,595   
  OOP 35,696,470,988 29,684,923,688 30,074,650,354   
  NGOs 4,916,278,185 18,590,859,396 34,127,880,676   
   Private Firms 862,337,797 1,984,914,629 3,296,540,893   
  Rest of the World 975,558,030 2,613,497,373 2,166,045,565   
   Others  2,534,652,516 -- --   
  Total 82,232,016,764 101,977,620,712 122,853,559,803   





Appendix C: Table of Past and Current Glucometers with Mobile Abilities, by Abilities 
 
             
 Table 6. 
a

































 HealthPia 2004 $380   X X   X  
 myglucohealth
82
 Entra Health 
Systems 
2009 $90  X    X  X  
 iBGStar
83
 Sanofi 2010 $72       X X  
 Telcare BGM
84
 Telcare 2011 $150   X     X  
 iHealth BG5
85





2013 Unknown      X X  
 Test N'GO
87
 ForaCare 2014 $84  X    X  X  




LifeScan, Inc 2014 $30  X    X  X  
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Appendix D: Mobile Assisted Management Abilities and Benefits. 
 
Patient Oriented Functions: 
Essential Attributes and Abilities:  
 Cellular glucometer is handheld device, the size of an typical smartphone or smaller 
 Battery operated with rechargeable battery 
 Must be identifiable or personalized to one patient 
 Receive and measure glucose testing strips 
 Instantly sends measurement results or during next available connection 
 User Interface (UI) displays measurements and whether the reading was on target 
 Glucometer can store a large quantity old readings 
 Can receive healthcare worker messages 
 Can input medication usage and cost 
 Alerts healthcare workers in case of an emergency 
 Can log in to a dedicated web-based patient portal for access to previous records, upload 
data, and connect with healthcare staff   
 Dynamically show locations of care clinics in surrounding vicinity based on network 
location 
 Alerts patients to educational campaigns in surrounding area 
Desirable Attributes and Abilities: 
 When available, measure blood glucose through non-invasive near infrared spectroscopy 
 UI displays other information such as medication alerts and basic education 
 UI displays health tips and reminders for care, depending on the patient and their needs 
 Can respond to healthcare worker messages or initiate communication 
 Patient may enter vitals and weight measurement if known 
 Strong color and intuitive displays to support for patients who struggle with literacy 
 
Healthcare Worker Oriented Functions: 
Essential Application Attributes and Abilities:  
 Dedicated healthcare worker web-based portal – containing most of the following 
 Manual and automated triage of patients 
 Triage or separate management of diabetic patients into categories such as location, 
patient demographics, co-morbidities, type 1 versus type 2 diabetes, insulin dependency, 
disease state, medication type, self-management ability, and more 




 Alerts for patient emergencies 
 Message patients through portal (SMS) 
 Request assistance from other staff 
 Offline access to Patients records, for use in the last mile when network not accessible 
 Manage other healthcare workers duties, as it relates to patient management 
 Automated reminders for patient management and other job functions 
 Supply/Distribution Chain information, relevant to medication distribution easily 
available 
 Automated and manual ordering of medications and supplies 
Desirable Attributes and Abilities: 
 Integration of the healthcare worker portal with existing electronic medical records to 
increase ease of use and adoption rates 
 Incentivize or reward patients through portal  
 Ability to call patients through portal, to phone or cellular glucometer if possible 
 
Ministry of Health or Other Payers, Oriented Functions: 
Essential Application Attributes and Abilities:  
 Patient data aggregated and filterable by location, patient demographics, co-morbidities, 
type 1 versus type 2 diabetes, insulin dependency, disease state, medication type, self-
management ability, and more 
 Management of Supply/Distribution Chain of medicines and supplies 
 Ability to organize campaigns through portal (educational, screenings, and more) 
 If insurer/payer, ability to verify patients use of equipment, to justify use. 
 Ability to easily incentivize or compensate for self-management 
Desirable Application Attributes and Abilities:  
 Integration of the payer portal with existing electronic health records to increase ease of 








Appendix E: Table of Development Hours Required for Core Components of MAM System 
 
            
  Table 7. Estimated Development Hours by Software Component and Use     
  System Component Software Component Description  Hours   
  
Client Mobile App 
Simple interface to communicate metrics, 
analysis and feedback to patient/family 
members 400   
  
Communication Service Layer Interfaces 
Messaging system to receive and send 
data between mobile and server 80   
  
Server 
Cloud-based Patient Record 
Storage 
Store patient overall and diabetic specific 
information 160   
  
Server Patient Compliance Module 
Module that understands/manages 
medical rules about diabetes and medical 
condition 240   
  
Server 
Coaching and Feedback 
Manager 
Manages messages and feedback 
(custom and default) to patient/family 
members 160   
  
Server Trend and Analysis 
Provides trend and analysis of data for 
daily or historical time periods 160   
  
Server HealthCare Manager Interface 
For healthcare providers to monitor 
individual patient results 400   
  
Server 
Healthcare Payer and MOH 
Management Interface 
For managing providers, facilities, and 
patient and system as a whole 200   
  
Server Medication Distribution Module 
For Managing medication suppliers and 
distribution of medication 600   
  Total Hours     2400   
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